Sexually transmitted infections in pregnancy: Prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries

Sexually Transmitted Infections

Volumn 81, Issue 4, 2005, Pages 294-302

  Mullick, Saiqa ^a   Watson Jones, D ^b,c   Beksinska, M ^d   Mabey, D ^b  

^a POPULATION COUNCIL   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c African Medical and Research Foundation Mwanza   (Tanzania)

^d Reproductive Health Research Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CLINDAMYCIN; METRONIDAZOLE; SILVER NITRATE; TETRACYCLINE;

CHLAMYDIASIS; CLINICAL TRIAL; DEVELOPING COUNTRY; GONORRHEA; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; META ANALYSIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; VAGINITIS;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL DIAGNOSIS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 23844481830     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2002.004077     Document Type: Review

References (115)

1. Mati J, Aggarwal V, Lucas S, et al. The Nairobi birth survey. 1. The study design, the population and outline results. J Obstet Gynecol East Cent Afr 1982;1:132-9.
2. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: WHO, 2001.
3. Sullivan EA, Abel M, Tabrizi S, et al. Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000. Sex Transm Dis 2003;30:362-6.
4. Fonck K, Kidula N, Jaoko W, et al. Validity of the vaginal discharge algorithm among pregnant women and non-pregnant women in Nairobi, Kenya. Sex Transm Infect 2000;76:33-8.
5. Gray H, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001;185:1209-17.
6. Watson-Jones D, Changalucha J, Balthazar G, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 2002;186:940-7.
7. McGregor JA, French JI, Richter R, et al. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol 1990;163(Pt 1):1580-91.
8. Temmerman M, Njagi E, Nagelkerke N, et al. Mass antimicrobial treatment in pregnancy. A randomized, placebo-controlled trial in a population with high rates of sexually transmitted diseases. J Reprod Med 1995;40:176-80.
9. Fiumara NJ, Fleming WL, Downing JG, et al. The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 1952;247:48-52.
10. Ingraham NR. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl 1950;31(Suppl 24):60-87.
11. Schulz KF, Cates W Jr, O'Mara PR. Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med 1987;63:320-5.
12. Watts TE, Larsen SA, Brown ST. A case-control study of stillbirths at a teaching hospital in Zambia, 1979-80: serological investigations for selected infectious agents. Bull World Health Organ 1984;62:803-8.
13. Donders GGG, Desmyter J, De Wet DH, et al. The association of gonorrhoea and syphilis with premature birth and low birth weight. Genitourin Med 1993;69:98-101.
14. Temmerman M, Lopita MI, Sanghvi HC, et al. The role of maternal syphilis, gonorrhoea and HIV-1 infections in spontaneous abortion. Int J STD AIDS 1992;3:418-22.
15. McDermott J, Steketee R, Larsen S, et al. Syphilis-associated perinatal and infant mortality in rural Malawi. Bull World Health Organ 1993;71:773-80.
16. Donders GGG, Desmyter J, Hooft P, et al. Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women. Sex Transm Dis 1997;24:94-101.
17. Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery. Am J Epidemiol 1989;129:1247-57.
18. Gravett MG, Nelson HP, DeRouen T, et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.
19. Harrison HR, Alexander ER, Weinstein L, et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA 1983;250:1721-7.
20. Plummer FA, Laga M, Brunham RC, et al. Postpartum upper genital tract infections in Nairobi, Kenya: epidemiology, etiology and risk factors. J Infect Dis 1987;156:92-8.
21. Beem MO, Saxon EM. Respiratory tract colonisation and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N Engl J Med 1977;296:306-10.
22. Laga M, Plummer FA, Nzanze H, et al. Epidemiology of ophthalmia neonatorum in Kenya. Lancet 1986;2:1145-9.
23. Mabey D, Hanlon P, Hanlon L, et al. Chlamydial and gonococcal ophthalmia neonatorum in the Gambia. Ann Trop Paediatr 1987;7:177-80.
24. Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 2003;36:502-9.
25. Mayaud P, Uledi E, Cornelissen J, et al. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect 1998;74(Supp 1):5139-46.
26. Lacey CJ, Milne JD. Preterm labour in association with Neisseria gonorrhoeae: case reports. Br J Vener Dis 1984;60:123-14.
27. Elliott B, Brunham RC, Laga M, et al. Maternal gonococcal infection as a preventable risk factor for low birth weight. J Infect Dis 1990;161:531-56.
28. Laga M, Plummer FA, Piot P, et al. Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med 1988;318:653-7.
29. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 1995;332:562-6.
30. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Lancet 1999;353:525-35.
31. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
32. Martius J, Krohn MA, Hillier SL, et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988;71:89-95.
33. McGregor JA, French JI, Seo K. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol 1993;169(pt 2):463-8.
34. McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
35. Gravett MG, Nelson HP, DeRouen T, et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.
36. Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732.
37. Oakeshott P, Hay P, Hay S, et al. Association between bacterial vaginosis or chlamydia infection and miscarriage before 16 weeks gestation: prospective community based cohort study. BMJ 2002;325:1334.
38. Joesoef MR, Hillier SL, Wiknjosastro S et al. Intravaginal clindamycin treatment for BV: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
39. Riduan JM, Hillier SL, Utomo B, et al. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 1993;169:175-8.
40. Donders GGG. Bacterial vaginosis during pregnancy: screen and treat? Eur J Obstet Gynecol Reprod Biol 1999;83:1-4.
41. Schwebke JR. Update of trichomoniasis. Sex Transm Infect 2002;78:378.
42. Krieger JN, Alderete JF. Trichomonas vaginalis and trichomoniasis. In:Holmes KK, Sparing PF, Mardh P-A, et al. Sexually transmitted diseases. 3rd ed. 1999;Chapter 43, 587-604.
43. Swygard H, Sena AC, Hobbs MM, et al. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect 2004;80:91-5.
44. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997;24:341-61.
45. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72.
46. Hardy PH, Hardy JB, Nell EE et al. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984;2:333-7.
47. Sutton MY, Sternberg M, Nsuami, et al. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: Prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999;181:656-62.
48. Bowden FJ, Garnett GP. Why is Trichomonas vaginalis ignored? Sex Transm Infect 1999;75:372-4.
49. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
50. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999;179:16-24.
51. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28.
52. O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI programmes. Sex Transm Infect 1999;75:377-84.
53. Rahman M, Paz-Bailey G, Regoeng M, et al. Changing patterns of STD in Botswana, 1993-2003. Abstract (No. 0334) presented at 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Ottawa, Canada, 27-30 July, 2003.
54. Weiss HA, Buve A, Robinson NJ, et al. Study group on heterogeneity of HIV epidemics in African cities. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001;15(Suppl 4):S97-108.
55. Del Mar Pujades Rodrigues M, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002;16:451-62.
56. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type-2 seropositive persons. A meta-analysis. J Infect Dis 2002;185:45-52.
57. Sheffield JS, Hollier LM, Hill JB, et al. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102:1396-403.
58. Scott LL. Prevention of perinatal herpes: prophylactic antiviral therapy? Clin Obstet Gynaecol 1999;42:134-48.
59. Brown ZA, Wald A, Morrow, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
60. Mindel A, Taylor J, Tideman RL, et al. Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect 2000;76:287-91.
61. Kulhanjian JA, Soroush V, Au DS, Bronzan RN, et al. Identification of women at unsuspected risk of primary infection with herpes simplex type-2 virus during pregnancy. N Engl J Med 1992;326:916-20.
62. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
63. Fawzi W, Msamanga G, Spiegelman D, et al. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania J. Acquir Immune Defic Syndr 2002;31:331-8.
64. UNAIDS 2003. Follow up to the 2001 United Nations General Assembly Special Session on HIV/AIDS. Progress Report on the Global Response to the HIV/AIDS Epidemic, 2003.
65. Ladner J, Leroy V, Hoffman P, et al. Chorioamnionitis and pregnancy outcome in HIV-infected African women. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:293-8.
66. Mwanyumba F, Gaillard P, Inion I, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 2002;29:262-9.
67. Temmerman M, Plummer FA, Mirza NB, et al. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990;4:1087-3.
68. Temmerman M, Chomba EN, Ndinya-Achola J, et al. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994;83:495-501.
69. Leroy V, Ladner J, Nyiraziraje M, et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. AIDS 1998;12:643-50.
70. Temmerman M, Ali FM, Ndinya Achola J, et al. Rapid increase of both HIV-1 infection and syphilis among pregnant women in Nairobi, Kenya. AIDS 1992;6:1181-5.
71. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000;283:1175-82.
72. Ogundele MO, Coulter JBS. HIV transmission through breastfeeding: problems and prevention. Ann Trop Paediatr 2003;23:91-106.
73. De Cock KM, Fowler MG, Mercier E. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000;283:1175-82.
74. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS 2000;14:2535-1.
75. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999;180:93-8.
76. John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001;183:206-12.
77. Coutsoudis A, Pillay K, Spooner E, et al. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet 1999;354:471-6.
78. Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother to child HIV transmission in Africa and inform rational intervention strategies. AIDS 2002;16:1991-9.
79. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002;51(RR-6):1-78.
80. World Health Organization. Guidelines for the management of sexually transmitted infections, WHO/HIV_AIDS/2001.01. Geneva: WHO, 2001.
81. Wilkinson D, Sach M, Connolly C. Epidemiology of syphilis in pregnancy in rural South Africa: opportunities for control. Trop Med Int Health 1997;2:57-62.
82. Jenniskens F, Obwaka E, Kirisuah S, et al. Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Gynaecol Obstet 1995;48(Suppl):S121-8.
83. Rotchford K, Lombard C, Zuma K, et al. Impact on perinatal mortality of missed opportunities to treat maternal syphilis in rural South Africa: baseline results from a clinic randomised controlled trial. Trop Med Int Health 2000;5:800-4.
84. Myer L, Wilkinson D, Lombard C, et al. Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial. Sex Transm Infect 2003;79:208-13.
85. Watson-Jones D, Gumodoka B, Weiss H, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 2002;186:948-57.
86. Terris-Prestholt F, Watson-Jones D, Mugeye K, et al. Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 2003;79:375-81.
87. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
88. Editorial. J Infect Dis 2003;187:721-4.
89. Moodley D, Moodley J, Coovadia H, et al. A multi-center randomized controlled trial of nevirapine versus a combination of zidovidine and lamivudine to reduce intrapartum and early postpartum mother-to-child-transmission of human immunodeficiency virus type 1. J Infect Dis 2003;187:725-35.
90. Farley T, Buyse D, Gaillard P. Efficacy of antiretroviral regimens for prevention of mother to child transmission of HIV and some programmatic issues. Background paper prepared for Technical Consultation on New Data on the Prevention of Mother to Child Transmission of HIV and their Policy Implications. Geneva, 11-13 October, 2000.
91. World Health Organization. Antiretroviral drugs and the prevention of mother to child transmission of HIV infection in resource constrained settings: Recommendations for use 2004 revision, Draft version - for public consultation. Geneva: WHO, 2004.
92. Scotland GS, van Teijlingen ER, van der Pol M, et al. A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 2003;17:1045-2.
93. Jourdain G, Ngo-Giang-Iluong N, Le Coeur S, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to Nevirapine-based antiretroviral therapy. N Engl J Med 2004;351:229-40.
94. Stringer EM, Sinkala M, Stringer JS, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS 2003;17:1377-2.
95. Rutenberg N, Baek C, Kalibala S, et al. HIV Voluntary counseling and testing: an essential component in preventing mother-to-child transmission of HIV. Horizons Research Summary. Washington, DC: Population Council, 2003.
96. World Health Assembly. Infant and young child nutrition. Geneva: World Health Organization, Resolution WHA54, 2, 2001.
97. World Health Organization. New data on the prevention of mother-to-child transmission of HIV and their policy implications: conclusions and recommendations, WHO Technical Consultation on behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV. Report No WHO/RHR/01.28. Geneva: WHO, 2001.
98. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1989;74:14-22.
99. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
100. Ndowa F. The syndromic management of genital discharge and genital ulcer diseases. Abstract (No. 0759) presented at 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Ottawa, Canada. 27-30 July, 2003.
101. Vuylsteke B. Current status of syndromic management of sexually transmitted infections in developing countries. Sex Transm Infect 2004;80:333-4.
102. Gaillard P, Mwanyumba F, Verhofstede C, et al. Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS 2001;15:389-96.
103. Gichangi PB, Ndinya-Achola JO, Ombete J, et al. Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history. Am J Obstet Gynecol 1997;177:680-4.
104. Laga M, Meheus A, Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989;67:471-7.
105. Isenberg SJ, Apt L, Wood M. The influence of perinatal infective factors on opthalmia neonatorum. J Pediatr Opthalmol Strabismus 1996;33:185-8.
106. Hira SK, Bhat GJ, Chikamata DM, et al. Syphilis intervention in pregnancy: Zambian demonstration project. Genitourin Med 1990;66:159-4.
107. Gaillard P, Melis R, Mwanyumba F, et al. Vulnerability of women in an African setting: lessons for mother-to-child HIV transmission prevention programmes. AIDS 2002;16:937-9.
108. Wolday D, G-Mariam Z, Mohammed Z. Risk factors associated with failure of syndromic treatment of sexually transmitted diseases among women seeking primary care in Addis Ababa. Sex Transm Infect 2004;80:392-4.
109. Rastogi S, Das B, Salhan S, et al. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet 2003;80:129-37.
110. Latif AS, Mason PR, Marowa E, et al. Risk factors for gonococcal and chlamydial cervical infection in pregnant and non-pregnant women in Zimbabwe. Cent Afr J Med 1999;45:10.
111. Msuya SE, Mbizvo E, Stray-Pedersen B, et al. Reproductive tract infections among women attending primary health care facilities in Moshi, Tanzania. East Afr Med J 2002;79:16-21.
112. Blankhart D, Muller O, Gresenguet G, et al. Sexually transmitted infections in young pregnant women in Bangui, Central African Republic. Int J STD AIDS 1999;10:609-14.
113. Marai W. Lower genital tract infections among pregnant women: a review. East Afr Med J 2001;78:581.
114. Ayisi JG, van Eijk AM, ter Kuile FO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in Western Kenya. AIDS 2003;17:585-94.
115. World Health Organization. Integrating care for reproductive health, sexually transmitted and other reproductive tract infections; a guide to essential practice. Geneva: WHO, January, 2004.